2019 Budget Focuses on Savings for Individuals and Families

NEXT STORY
Vical to Discontinue Clinical Development of VL-2397 as it Considers Near Term Strategic Alternatives
PREV STORY
SeaSpine Appoints Kim Commins-Tzoumakas and Renee Gaeta to its Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Helix BioPharma Corp. collaborator ProMab Biotechnologies to present at the CAR-TCR Summit 2018 in Boston

RICHMOND HILL, Ontario, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), ...

author_avatar
NASDAQ Market News

Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated

MINNEAPOLIS, March 21, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

author_avatar
NASDAQ Market News

Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017

RANCHO CORDOVA, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...

author_avatar
NASDAQ Market News